Adalimumab Injection
制剂 FDF · Injection · 0.8ml: 40mg
制剂 FDFConfidentiality：公开
- INN / Generic Name
- Adalimumab Injection
- Dosage Form
- Injection
- Strength
- 0.8ml: 40mg
- Therapy Area
- Immunology & Inflammation
- Indication
- Rheumatoid arthritis; Juvenile idiopathic arthritis; Ankylosing spondylitis; Psoriasis; Pediatric plaque psoriasis; Crohn's disease; Pediatric Crohn's disease; Uveitis
- Current Status
- 官方 FDF 授权目录（UB651）
- GMP Certification
- CN - NMPA; PIC/S; SA - SFDA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 已完成注册（目标市场可转移 / 视市场 DCP·NP）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
ChinaSaudi Arabia
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —